XYLEM ($XYL) posted quarterly earnings results for Q4 2025 on Tuesday, February 10th. The company reported earnings of $1.42 per share, missing estimates of $1.42 by $0.00. The company also reported revenue of $2,397,000,000, missing estimates of $2,398,115,780 by $-1,115,780.
You can see Quiver Quantitative's $XYL stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
XYLEM Insider Trading Activity
XYLEM insiders have traded $XYL stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $XYL stock by insiders over the last 6 months:
- CLAUDIA S TOUSSAINT (EVP, CPSO) sold 10,421 shares for an estimated $1,590,661
- LISA GLATCH sold 4,900 shares for an estimated $689,231
- VICTORIA D HARKER sold 1,700 shares for an estimated $251,837
- GERI-MICHELLE MCSHANE (VP, CAO) sold 1,000 shares for an estimated $139,962
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
XYLEM Hedge Fund Activity
We have seen 512 institutional investors add shares of XYLEM stock to their portfolio, and 495 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 2,688,970 shares (+58.1%) to their portfolio in Q3 2025, for an estimated $396,623,075
- PRICE T ROWE ASSOCIATES INC /MD/ removed 1,237,845 shares (-32.9%) from their portfolio in Q3 2025, for an estimated $182,582,137
- SCHRODER INVESTMENT MANAGEMENT GROUP added 1,137,342 shares (+2055.2%) to their portfolio in Q3 2025, for an estimated $167,757,945
- INVESCO LTD. removed 768,176 shares (-18.9%) from their portfolio in Q3 2025, for an estimated $113,305,960
- AMUNDI removed 757,760 shares (-13.3%) from their portfolio in Q3 2025, for an estimated $111,769,600
- VOYA INVESTMENT MANAGEMENT LLC added 733,860 shares (+544.0%) to their portfolio in Q3 2025, for an estimated $108,244,350
- AXA S.A. removed 725,749 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $107,047,977
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
XYLEM Analyst Ratings
Wall Street analysts have issued reports on $XYL in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- William Blair issued a "Outperform" rating on 01/26/2026
- UBS issued a "Buy" rating on 11/06/2025
- Citigroup issued a "Buy" rating on 10/29/2025
- Barclays issued a "Overweight" rating on 10/29/2025
- Stifel issued a "Buy" rating on 10/29/2025
- RBC Capital issued a "Outperform" rating on 10/29/2025
To track analyst ratings and price targets for XYLEM, check out Quiver Quantitative's $XYL forecast page.
XYLEM Price Targets
Multiple analysts have issued price targets for $XYL recently. We have seen 7 analysts offer price targets for $XYL in the last 6 months, with a median target of $175.0.
Here are some recent targets:
- William Grippin from Barclays set a target price of $166.0 on 01/07/2026
- Brett Linzey from Mizuho set a target price of $150.0 on 01/05/2026
- Joseph Giordano from TD Cowen set a target price of $135.0 on 12/05/2025
- Damian Karas from UBS set a target price of $175.0 on 11/06/2025
- Nathan Jones from Stifel set a target price of $178.0 on 10/29/2025
- Deane Dray from RBC Capital set a target price of $176.0 on 10/29/2025
- Andrew Kaplowitz from Citigroup set a target price of $182.0 on 10/29/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
